Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Formulations of Curcumin Nanoparticles for Brain Diseases
Marí­a Luisa Del Prado-Audelo, Isaac H. Caballero‐Florán, Jorge A. Meza-Toledo, et al.
Biomolecules (2019) Vol. 9, Iss. 2, pp. 56-56
Open Access | Times Cited: 155

Showing 1-25 of 155 citing articles:

Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases
Nur Shafika Mohd Sairazi, K. N. S. Sirajudeen
Evidence-based Complementary and Alternative Medicine (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 162
Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges
Md. Habibur Rahman, Johny Bajgai, Ailyn Fadriquela, et al.
Molecules (2021) Vol. 26, Iss. 17, pp. 5327-5327
Open Access | Times Cited: 105
Curcumin-Based Nanomedicines in the Treatment of Inflammatory and Immunomodulated Diseases: An Evidence-Based Comprehensive Review
Lucas Fornari Laurindo, Gabriel Magno de Carvalho, Bárbara de Oliveira Zanuso, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 229-229
Open Access | Times Cited: 52
Evolving therapeutic interventions for the management and treatment of Alzheimer’s disease
Faizan Ahmad, Anik Karan, Rashi Sharma, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102229-102229
Closed Access | Times Cited: 16
Curcumin Solubility and Bioactivity Enhancement Through Amorphization with Tryptophan via Supercritical Fluid Technology
Ewa Garbiec, Natalia Rosiak, Szymon Sip, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 855-855
Open Access | Times Cited: 2
Curcumin, Hormesis and the Nervous System
Maria Scuto, Cesare Mancuso, Barbara Tomasello, et al.
Nutrients (2019) Vol. 11, Iss. 10, pp. 2417-2417
Open Access | Times Cited: 142
Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders
Seyed Zachariah Moradi, Saeideh Momtaz, Zahra Bayrami, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 136
Molecular mechanism of curcumin action in signaling pathways: Review of the latest research
Przemysław Liczbiński, Jaromir Michałowicz, Bożena Bukowska
Phytotherapy Research (2020) Vol. 34, Iss. 8, pp. 1992-2005
Closed Access | Times Cited: 129
Natural Compounds as Inhibitors of Aβ Peptide Aggregation: Chemical Requirements and Molecular Mechanisms
Katiuscia Pagano, Simona Tomaselli, Henriette Molinari, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 93
Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems
Daniela Plachá, Josef Jampílek
Pharmaceutics (2021) Vol. 13, Iss. 1, pp. 64-64
Open Access | Times Cited: 91
Potential therapeutic effects of curcumin mediated by JAK/STAT signaling pathway: A review
Milad Ashrafizadeh, Hossein Rafiei, Reza Mohammadinejad, et al.
Phytotherapy Research (2020) Vol. 34, Iss. 8, pp. 1745-1760
Closed Access | Times Cited: 81
A Reevaluation of Chitosan-Decorated Nanoparticles to Cross the Blood-Brain Barrier
Hernán Cortés, Sergio Alcalá-Alcalá, Isaac H. Caballero‐Florán, et al.
Membranes (2020) Vol. 10, Iss. 9, pp. 212-212
Open Access | Times Cited: 74
Mutual Two-Way Interactions of Curcumin and Gut Microbiota
Ryszard Pluta, Sławomir Januszewski, Marzena Ułamek-Kozioł
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 1055-1055
Open Access | Times Cited: 72
Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases
Bahare Salehi, Marí­a Luisa Del Prado-Audelo, Hernán Cortés, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 3, pp. 746-746
Open Access | Times Cited: 72
Transferrin-functionalized lipid nanoparticles for curcumin brain delivery
Ana Rute Neves, Lisa van der Putten, Joana Queiroz, et al.
Journal of Biotechnology (2021) Vol. 331, pp. 108-117
Closed Access | Times Cited: 61
Enhanced neuroprotective and antidepressant activity of curcumin-loaded nanostructured lipid carriers in lipopolysaccharide-induced depression and anxiety rat model
Sana Rubab, Komal Naeem, Isra Rana, et al.
International Journal of Pharmaceutics (2021) Vol. 603, pp. 120670-120670
Closed Access | Times Cited: 57
Nano‐Derived Therapeutic Formulations with Curcumin in Inflammation‐Related Diseases
Cristina Quispe, Natália Martins, Maria Letizia Manca, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 57
The Credible Role of Curcumin in Oxidative Stress-Mediated Mitochondrial Dysfunction in Mammals
Muthuswamy Sathyabhama, Loganathan Chandramani Priya Dharshini, Adhimoolam Karthikeyan, et al.
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1405-1405
Open Access | Times Cited: 55
Combination Therapy Comprising Paclitaxel and 5-Fluorouracil by Using Folic Acid Functionalized Bovine Milk Exosomes Improves the Therapeutic Efficacy against Breast Cancer
Dulla Naveen Kumar, Aiswarya Chaudhuri, Deepa Dehari, et al.
Life (2022) Vol. 12, Iss. 8, pp. 1143-1143
Open Access | Times Cited: 53
Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation
Javad Sharifi‐Rad, Simona Rapposelli, Simona Sestito, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1515-1515
Open Access | Times Cited: 49
Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease
Rajeev Taliyan, Violina Kakoty, K C Sarathlal, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 528-550
Closed Access | Times Cited: 45
siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary review
Saman Sargazi, Rabia Arshad, Reza Ghamari, et al.
Cell Biology International (2022) Vol. 46, Iss. 9, pp. 1320-1344
Open Access | Times Cited: 42
Effect of nano‐curcumin on various diseases: A comprehensive review of clinical trials
Shirin Hassanizadeh, Mehrnaz Shojaei, Mohammad Bagherniya, et al.
BioFactors (2023) Vol. 49, Iss. 3, pp. 512-533
Closed Access | Times Cited: 41
Curcumin-based nanotechnology approaches and therapeutics in restoration of autoimmune diseases
Niloufar Rahiman, Yuliya V. Markina, Prashant Kesharwani, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 264-286
Closed Access | Times Cited: 40
Synthesis, characterization and evaluation of anti-arthritic and anti-inflammatory potential of curcumin loaded chitosan nanoparticles
Hafiz Muhammad Asif, Farah Zafar, Sarfaraz Ali Ghumro, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top